PTX-100 CTCL Phase 2a study reaches review milestone
Filed with ASX · · 3 pages · English
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- Prescient Therapeutics Opens SPP to Raise $7m Today
- Appendix 4E and 2026 Annual Report
- June 2026 Quarterly Update and Appendix 4C
- March 2026 Quarterly Update and Appendix 4C
- Appendix 4D and Half Year Financial Report
Later from Prescient Therapeutics
- PTX Successfully Completes $6m Raise Via SPP and Placement
- September 2026 Quarterly Update and Appendix 4C
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics